Sort   by:  
 Page size 
TranscriptomicsIdentification of novel long non-coding RNAs in prostate cancers
Long non-coding RNAs show highly tissue and disease specific expression profiles. We analyzed prostate cancer and normal adjacent prostate samples to identify cancer-specific transcripts and found 334 candidates, of which 15 were validated by RT-PCR. 8 Prostate cancer samples from radical prostatect...
ORGANISM(S): Homo sapiens 
2015-03-02 | E-GEOD-59745 | biostudies-arrayexpress
ProteomicsProfiling of antibodies against prostate cancer xenograft-released proteins
The present study describes a novel xenograft-based biomarker discovery platform and proves its usefulness in the discovery of novel serum markers for prostate cancer (PCa). By immunizing immuno-competent mice with serum from nude mice bearing PCa xenografts, an antibody response against xenograft-d...
ORGANISM(S): Mus musculus 
2011-12-16 | E-GEOD-16220 | biostudies-arrayexpress
UnknownComparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.
Not available
S-EPMC9541488 | biostudies-literature
UnknownConsensus molecular subtype classification of colorectal adenomas.
Not available
S-EPMC6221003 | biostudies-literature
UnknownActive Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative.
Not available
S-EPMC9257656 | biostudies-literature
UnknownReasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium.
Not available
S-EPMC8542419 | biostudies-literature
UnknownA first step towards a global nomogram to predict disease progression for men on active surveillance.
Not available
S-EPMC8039580 | biostudies-literature
UnknownUsing the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patients.
Not available
S-EPMC8261406 | biostudies-literature
UnknownPersonalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance.
Not available
S-EPMC7818468 | biostudies-literature
UnknownInterim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Not available
S-EPMC6880781 | biostudies-literature
Sort   by:  
 Page size